Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[nep2134]

Wow, this is most interesting. If nothing else having invested in RCP in doing my due diligence I learned how to read and understand stuff like this. I understand exactly what they are talking about. This could be a HUGE game changer.

Now note what they did. They were looking into curcumin. But they didn't waste their time on it, which has shown inconsistent results. And it can't be patented. They slightly modified the active molecule and they can patent that. And then they hit the jackpot with the new molecule working better than the original.

And the MOA is most interesting. Especially with Mullan saying beta amyloid was a 25 yr waste of time. Knowing how the immune system works, I can totally see how this could work. It's like attacking the problem from a different angle. Most interesting.

I want to stress though. I could care less about alzheimer's and anatabine. There is so much more to anatabine. I am actively looking into doing mice studies.